Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-128994
Filing Date
2023-05-01
Accepted
2023-05-01 09:27:05
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d481829d10ka.htm   iXBRL 10-K/A 721760
2 EX-31.3 d481829dex313.htm EX-31.3 10926
3 EX-31.4 d481829dex314.htm EX-31.4 11190
  Complete submission text file 0001193125-23-128994.txt   1070007

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amrn-20221231.xsd EX-101.SCH 5757
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amrn-20221231_cal.xml EX-101.CAL 675
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrn-20221231_def.xml EX-101.DEF 19659
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20221231_lab.xml EX-101.LAB 27440
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20221231_pre.xml EX-101.PRE 21089
10 EXTRACTED XBRL INSTANCE DOCUMENT d481829d10ka_htm.xml XML 10525
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21392 | Film No.: 23870641
SIC: 2834 Pharmaceutical Preparations